PER-030-02已完成未知
A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Pancreas cancer that cannot be removed by surgery OR that has spread to a new site in your body.
- •You must have one tumor that can be physically measured or scanned by the doctor.
- •You have not had any chemotherapy, immunotherapy, biologic therapy, or hormonal therapy for pancreas cancer, including 5-FU.
- •You cannot have any radiation for 4 weeks before starting this study, and you cannot have radiation to the whole pelvis.
排除标准
- •Treatment with any medication or device that has not been approved by regulatory agencies, like the FDA, at the time you enter the study.
- •Documentation that the cancer has spread to your brain.
- •Pregnant or breastfeeding.
- •A second primary cancer.
- •Unable to stop aspirin or non-steroidal anti-inflammatory agents (like ibuprofen) for 5-8 days.
研究者
相似试验
进行中（未招募）
不适用
A Phase 1 and 2 Clinical Trial of ALIMTA (Pemetrexed) in Combination with Carboplatin in Patients with Recurrent Ovarian or Primary Peritoneal Cancer(Sweden will participate in Phase 2 of this trial, only)platinum sensitive recurrent ovarian or primary peritoneal cancerMedDRA version: 8.1Level: LLTClassification code 10033130Term: Ovarian cancer NOSEUCTR2004-002782-20-SEEli Lilly and Company Limited85
进行中（未招募）
不适用
A Phase 1 and 2 Clinical Trial of ALIMTA (Pemetrexed) in Combination with Carboplatin in Patients with Recurrent Ovarian or Primary Peritoneal CancerEUCTR2004-002782-20-DEEli Lilly and Company Limited110
进行中（未招募）
1 期
A Randomised Phase 3 Trial of Alimta (pemetrexed) and Carboplatin versus Etoposide and Carboplatin in Extensive-Stage Small Cell Lung Cancer.Extensive stage Disease Small cell Lung cancerMedDRA version: 8.1Level: LLTClassification code 10041068Term: Small cell lung cancer extensive stageEUCTR2006-001173-14-NLEli Lilly and Company Limited1,820
进行中（未招募）
不适用
A Randomised Phase 3 Trial of Alimta (pemetrexed) and Carboplatin versus Etoposide and Carboplatin in Extensive-Stage Small Cell Lung Cancer.Extensive stage Disease Small cell Lung cancerMedDRA version: 8.1Level: LLTClassification code 10041068Term: Small cell lung cancer extensive stageEUCTR2006-001173-14-GBEli Lilly and Company Limited1,820
进行中（未招募）
不适用
A Randomised Phase 3 Trial of Alimta (pemetrexed) and Carboplatin versus Etoposide and Carboplatin in Extensive-Stage Small Cell Lung Cancer.Extensive stage Disease Small cell Lung cancerMedDRA version: 8.1Level: LLTClassification code 10041068Term: Small cell lung cancer extensive stageEUCTR2006-001173-14-PTEli Lilly and Company Limited1,820